Related by context. Frequent words. (Click for all words.) 71 CORT # 70 Entereg R 66 squalamine 65 refractory chronic lymphocytic 65 Belinostat 64 Panzem R 64 Bicifadine 64 Advancing Drugs 63 TOCOSOL Paclitaxel 63 valopicitabine 63 talactoferrin 63 R sorafenib tablets 63 SILENOR TM 63 sodium Injection 63 vernakalant oral 63 TranSwitch indebtedness 63 omecamtiv mecarbil 63 Barroway LLP Marc 63 Combidex 63 PXD# 63 Phenoptin 62 PS# [001] 62 CONTAINS FORWARD LOOKING STATEMENTS 62 elotuzumab 62 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 62 Cetrorelix 62 IS FOR INFORMATIONAL 62 TELCYTA 62 www.combinatorx.com 62 HYPOTHETICAL OR SIMULATED PERFORMANCE 62 MGCD# MGCD# [002] 62 Fibrillex TM 62 SARMs 62 liposomal formulation 62 Initiates Phase 62 Completes Enrollment 62 TRANSDUR Sufentanil 61 Initiate Phase 61 VERIFICATION OF THE 61 GVAX R 61 oral calcitonin 61 Aerosurf 61 Inc Therapeutic Competitors 61 Exelbine 61 RGB # 61 Nasdaq VRTX 61 Phase IIa clinical trials 61 A. Topaz Esq 61 vernakalant iv 61 ASONEP 61 ALN TTR# 61 Recombinant Human 61 alvimopan 61 Cinryze TM 61 lewd racist 61 Pivotal Phase III 60 ATryn ® 60 FITCH 'S CODE OF 60 Allovectin 7 R 60 Actimmune R 60 FermaVir 60 SAR# [004] 60 PEG SN# 60 celgosivir 60 IMC #B 60 Patient Enrollment 60 apaziquone 60 By Thomas Gryta 60 Drug Candidate 60 RESULTS HAVE CERTAIN INHERENT 60 ELND# 60 ACTION TAKEN BY 60 unter www.ad hoc news.de 60 Genaera Corporation 60 SHALL NOT CONSTITUTE AN 60 Medarex logo 60 ENTER OR USE 60 DEBT AND IDENTITY 60 Presents Positive 60 OR SIMILAR STATEMENTS ARE 60 MATERIALLY FROM ANY FUTURE 60 RELATIVELY GOOD PERFORMANCE DETECTED 60 irresponsible nuisances 60 INFORMATION SET FORTH HEREIN 60 OR ANYONE ELSE FOR 60 REPORTS FILED FROM 60 YOU IN RELIANCE 60 ATK undertakes 60 forodesine 60 AND SHOULD ALSO 60 ARE MADE AS 60 phase IIb clinical 60 Icatibant 60 THE TERMS AND CONDITIONS 60 Resverlogix Corp. 59 Full Prescribing Information 59 tezampanel 59 OF THIS SITE 59 RR Donnelley disclaims 59 FDA Accepts 59 www.syntapharma.com